Evidence map›Paper›PMID 35142878›Full record

ArticleDiabetologia2022

Early DNA methylation changes in children developing beta cell autoimmunity at a young age.

Inna Starskaia, Essi Laajala, Toni Grönroos, Taina Härkönen, Sini Junttila, Roosa Kattelus, Henna Kallionpää, Asta Laiho, Veronika Suni, Vallo Tillmann and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. DNA Methylation NearPediatric diabetes · 2023
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Inna StarskaiaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0003-4349-439X
Essi LaajalaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0002-3382-7966
Toni GrönroosTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0002-2830-8192
Taina HärkönenPediatric Research Center, Children's Hospital, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland.
Sini JunttilaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0003-3754-5584
Roosa KattelusTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Henna KallionpääTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0001-6425-7006
Asta LaihoTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0001-6217-6659
Veronika SuniTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0001-8269-7291
Vallo TillmannChildren's Clinic of Tartu University Hospital, Tartu, Estonia.ORCID 0000-0002-5279-4493
Riikka LundTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0002-1068-5918
Laura L EloTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID 0000-0001-5648-4532
Harri LähdesmäkiDepartment of Computer Science, Aalto University, Espoo, Finland.ORCID 0000-0002-0373-139X
Mikael KnipPediatric Research Center, Children's Hospital, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-0474-0033
Ubaid Ullah KalimTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. ubaid.ullah@utu.fi.ORCID 0000-0002-2539-2296
Riitta LahesmaaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. rilahes@utu.fi.ORCID 0000-0002-4782-9567
Åbo Akademi University · FIUniversity of Helsinki · FIAalto University · FITartu University Hospital · EEUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisType 1 diabetes is a chronic autoimmune disease of complex aetiology, including a potential role for epigenetic regulation. Previous epigenomic studies focused mainly on clinically diagnosed individuals. The aim of the study was to assess early DNA methylation changes associated with type 1 diabetes already before the diagnosis or even before the appearance of autoantibodies.

methodsReduced representation bisulphite sequencing (RRBS) was applied to study DNA methylation in purified CD4

resultsWe identified 79, 56 and 45 differentially methylated regions in CD4 CONCLUSIONS/

interpretationThese preliminary results provide novel insights into cell type-specific differential epigenetic regulation of genes, which may contribute to type 1 diabetes pathogenesis at the very early stage of disease development. Should these findings be validated, they may serve as a potential signature useful for disease prediction and management.

Indexed as

Diabetes Mellitus, Type 1DNA MethylationAutoantibodiesAutoimmunityCD8-Positive T-LymphocytesChildCpG IslandsEpigenesis, GeneticHumansLeukocytes, MononuclearAutoantibodiesDNA methylationEpigeneticsT cellsType 1 diabetes

Identifiers

PMID35142878
PMCPMC8960578
OpenAlexW4211085498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.